Diagnosis of minimal residual disease in bone marrow and blood in cancer patients - Methods and clinical implications

Acta Oncologica

Volumn 37, Issue 5, 1998, Pages 455-462

  Kvalheim, G ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CROSS REACTION; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPHOMA; MINIMAL RESIDUAL DISEASE; OCCULT CANCER; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BONE MARROW; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM, RESIDUAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0031732284     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698430403     Document Type: Article

References (50)

1. Funke I, Schraut W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remaining to be substantiated. JCO 1998; 16: 557-66.
2. Zippelius A, Kufer Å, Honold G, et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. JCO 1998; 15; 2701-8.
3. Pantel K, Schlimok G, Angstwurm M, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994; 3: 165-73.
4. Kvalheim G, Øgreid P, Wæhre H, et al. Detection of micrometastasis in bone marrow and blood in non-metastatic prostate cancer. First International Symposium on Minimal Residual Cancer 1996; 3: 32.
5. Kvalheim G, Pharo A, Holte H, Gilen E, Erikstein B, Nesland J. High dose therapy of stage II breast cancer patients. Tumour cell contamination and purging. Bone Marrow Transplant 1998; 21 (Suppl. 1): 58.
6. Naume B, Borgen E, Beiske K, et al. Detection of isolated breast cancer cells in peripheral blood or bone marrow by immunomagnetic techniques. J Hematother 1997; 6: 103-14.
7. Gribben JG, Neuberg D, Freedman AS, et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 12: 3449-57.
8. Lin F, Van Rhee F, Goldman JM, Cross NCP. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 1996; 87: 4473-8.
9. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994; 12: 475-82.
10. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 1996; 14: 1868-76.
11. Krismann M, Todt B, Schröder J, et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995; 13: 2769-75.
12. Diel IJ, Kaufmann M, Costa SD, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. JNCO 1997; 88: 1652-8.
13. Mansi JL, Easton D, Berger U, et al. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer 1991; 27: 1552-5.
14. Schlimok G, Funke I, Holzmann B, et al. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 1987; 84: 8672-6.
15. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991; 9: 1749-56.
16. Harbeck N, Untch M, Pache L, Eiermann W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 1994; 69: 566-71.
17. Lindemann F, Schlimok G, Dirschedl P, Witte J, Rietmuller G. Prognostic significance of micrometastaic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340: 685-9.
18. Schlimok G, Funke I, Pantel K, et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991; 27: 1461-5.
19. Thorban S, Roder JD, Pantel K, Siewert JR. Epithelial tumour cells in bone marrow of patients with panreatic carcinoma detected by immunocytochemical staining. Eur J Cancer 1996; 32A: 363-5.
20. Thorban S, Roder JD, Nekarda H, Funk A, Rudiger S, Pantel K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. JNCO 1996; 88: 1222-7.
21. Schlimok G, Pantel K, Loibner H, Fackler-Schwalbe I, Rietmuller G. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 1995; 31A: 1799-803.
22. Mansi JL, Berger U, Wilson P, Shearer R, Coombes RC. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 1988; 139: 545-8.
23. Oberneder R, Kriegmair M, Pantel K, Staudte S, Hofstetter A, Rietmuller G. Prognostic relevance of micrometastatic tumor cells in bone marrow of patients with genitourinary tract tumors. J Urol 1994; 151: 413.
24. Pantel K, Aignherr C, Køllermann J, Caprano J, Rietmuller G, Kollermann MW. Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer: Eur J Cancer 1995; 31A: 1627-32.
25. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small lung cancer without overt metastases. Lancet 1996; 347: 649-53.
26. Beiske K, Myklebust AT, Aamdal S, Langholm R, Jakobsen E, Fodstad Ø. Detection of bone marrow metastases in small cell lung cancer patients: comparison of immunologic and morphologic methods. Am J Path 1992; 19: 1-7.
27. Shpall EJ, Jones RB. Release of tumor cells from bone marrow. Blood 1994; 83: 623-5.
28. Hardingham JE, Kotasek D, Sage RE, et al. Significance of molecular marker-positive cells after autologous peripheral-blood stem-cells transplantation for Non-Hodgkin's Lymphoma. J Clin Oncol 1995; 13: 1073-9.
29. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874-8.
30. Deggerdal AH, Pettersen F, Kvalheim G, et al. Semiquantitative polymerase chain reaction for t(14; 18) in follicular lymphomas: a colorimetric approach. Lab Invest 1995; 4: 1-7.
31. Neale GAM, Menarguez J, Kitchingman GR, et al. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse. Blood 1991; 78: 739-47.
32. Corradini P, Voena C, Astolfi M, et al. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1995; 85: 1596-602.
33. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994; 12: 725-9.
34. Neumaier M, Gerhard M, Wagener C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 1995; 159: 43-7.
35. Eschwège P, Dumas F, Blanchet P, et al. Hematogenus dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995; 346: 1528-30.
36. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman UH. Detection of prostatic cells in peripheral blood; correlation with serum concentrations of prostate-specific antigen. Clin Chem 1995; 41: 182-6.
37. Moreno JG, Croce CM, Fischer R, et al. Detection of hematogenous micrometastasis patients with prostate cancer. Cancer Res 1992; 52: 6110-2.
38. Olsson CA, De Vries GM, Benson MC, et al. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular stating of prostate cancer. Br J Urol 1996; 77: 411-7.
39. Wood DP Jr, Banks ER, Humphreys S, McRoberts JW, Rangnekar VM. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 1994; 74: 9.
40. Miller JF, Ahmann FR, Drach GW, Emerson SS, Bottaccini MR. The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer. J Urol 1992; 147: 956-61.
41. Loric S, Dumas F, Eschwege P, et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem 1195; 41/12: 1698-704.
42. Smith MR, Biggar S, Hussain M. Prostate-specific messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 1995; 55: 2640-4.
43. Gala JL, Heusterspreute M, Loric S, et al. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. Clin Chem 1998; 44: 472-81.
44. Brossart P, Schmier JW, Krüger S, et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995; 55: 4065-8.
45. Hoon DSB, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995; 13: 2109-16.
46. Mattano LA Jr, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992; 52: 4701-5.
47. Kvalheim G. Detection of occult tumour cells in bone marrow and blood in breast cancer patients. Acta Oncol 1997; 35: 13-8.
48. Kvalheim G, Wang MY, Pharo A, et al. Purging of tumor cells from leukapheresis products: experimental and clinical aspects. J Hematother 1996; 5: 429-38.
49. + cells. Leukemia 1992; 6: 845-52.
50. Naume B, Borgen E, Beiske K, et al. Negative immunomagnetic enrichment of cytokeratin-positive cells from bone marrow peripheral blood stem cell products in breast cancer patients. ISHAGE 3rd International Meeting 1997; 25: 132.